Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir

Antiviral Research

Volumn 40, Issue 1-2, 1998, Pages 53-56

  Neyts, Johan ^a   De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Acyclovir; CellCept ; Herpesvirus; Immunosuppression; Mycophenolate mofetil (MFF)

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DRUG POTENTIATION; HERPES; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; TOPICAL DRUG ADMINISTRATION;

EID: 0032402248     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(98)00047-3     Document Type: Article

References (9)

1. Badley A.D., Seaberg E.C., Porayko M.K., Wiesner R.H., Keating M.R., Wilhelm M.P., Walker R.C., Patel R., Marshall W.F., DeBernardi M., Zetterman R., Steers J.L., Paya C.V. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database. Transplantation. 64:1997;66-73.
2. De Clercq E., Descamps J., Verhelst G., Walker R.T., Jones A.S., Torrence P.F., Shugar D. Comparative efficacy of different antiherpes drugs against different strains of herpes simplex virus. J. Infect. Dis. 141:1980;563-574.
3. Kletzmayr J., Kotzmann H., Popow-Kraupp T., Kovarik J., Klauser R. Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients. J. Am. Soc. Nephrol. 7:1996;325-330.
4. Lipsky J.J. Mycophenolate mofetil. Lancet. 348:1996;1357-1359.
5. Neyts J., Andrei G., De Clercq E. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the anti-herpes virus activity of acyclovir, ganciclovir and penciclovir. Antimicrob. Agents Chemother. 42:1998;216-222.
6. Patel R. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation. 61:1996;1279-1289.
7. Ransom J.T. Mechanism of action of mycophenolate mofetil. Ther. Drug Monit. 17:1995;681-684.
8. Snoeck R., Andrei G., Gerard M., Silverman A., Hedderman A., Balzarini J., Sadzot-Delvaux C., Tricot G., Clumeck N., De Clercq E. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clin. Infect. Dis. 18:1994;570-578.
9. Zaia J.A. Prophylaxis and treatment of CMV infections in transplantation. Adv. Exp. Med. Biol. 394:1996;117-134.